Werkstrasse 2
Lenzing 4860
Austria
43 7672 7010
https://www.lenzing.com
Settore/i:
Settore:
Impiegati a tempo pieno: 7.748
Nome | Titolo | Retribuzione | Esercitate | Anno di nascita |
---|---|---|---|---|
Mr. Stephan Helmut Sielaff | CEO & Chairman of Management Board | N/D | N/D | 1966 |
Dr. Nico Reiner | CFO & Member of Management Board | N/D | N/D | 1969 |
Mr. Christian Skilich L.L.M., M.B.A. | Chief Pulp & Technology Officer and Member of Management Board | N/D | N/D | 1968 |
Sebastien Knus | Vice President of Capital Markets & Investor Relation | N/D | N/D | N/D |
Magistrate Dominic Kofner | Vice President Corporate Communications & Public Affairs | N/D | N/D | N/D |
Mr. Johann Huber | Managing Director of Plastics | N/D | N/D | N/D |
Dr. Walter Bickel | Chief Transformation Officer | N/D | N/D | 1959 |
Lenzing Aktiengesellschaft, together with its subsidiaries, produces and markets wood-based cellulosic fibers for the textile and nonwoven sectors, and industrial applications. The company operates through Division Fiber, Division Pulp, and Others segments. It offers lyocell and modal fibers for applications in textiles products, such as denim, activewear, and lingerie and underwear; hygiene articles, which include baby wipes, facial sheet masks, and surface cleaning; and protective wear, engineered products, and packaging products under the LENZING, TENCEL, VEOCEL, and LENZING ECOVERO brand names. The company also provides biorefinery products comprising acetic acid biobased, furfural biobased, magnesium lignosulphonate biobased, soda ash, sodium sulphate, and xylose. It also engages in the training and personnel development activities. The company operates in Austria; rest of Europe; Asia; North, Central, and South America; and internationally. Lenzing Aktiengesellschaft was formerly known as Chemiefaser Lenzing AG and changed its name to Lenzing Aktiengesellschaft in 1984. The company was founded in 1892 and is headquartered in Lenzing, Austria.
L'ISS Governance QualityScore di Lenzing Aktiengesellschaft al 1 aprile 2024 è 8. I criteri di valutazione fondamentali sono revisione: 10; Consiglio di Amministrazione: 6; diritti degli azionisti: 6; retribuzione: 8.